Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The zinc finger transcription factor
GATA-3
is of critical importance for early T cell development and commitment of Th2 cells. To study the role of
GATA-3
in early T cell development, we analyzed and modified
GATA-3
expression in vivo. In mice carrying a targeted insertion of a lacZ reporter on one allele, we found that
GATA-3
transcription in CD4(+)CD8(+) double-positive thymocytes correlated with the onset of positive selection events, i.e., TCRalphabeta up-regulation and CD69 expression. LacZ expression remained high ( approximately 80% of cells) during maturation of CD4 single-positive (SP) cells in the thymus, but in developing CD8 SP cells the fraction of lacZ-expressing cells decreased to <20%. We modified this pattern by enforced
GATA-3
expression driven by the CD2 locus control region, which provides transcription of
GATA-3
throughout T cell development. In two independent CD2-GATA3-transgenic lines, approximately 50% of the mice developed thymic lymphoblastoid tumors that were CD4(+)CD8(+/low) and mostly CD3(+). In tumor-free CD2-GATA3-transgenic mice, the total numbers of CD8 SP cells in the thymus were within normal ranges, but their maturation was hampered, as indicated by increased apoptosis of CD8 SP cells and a selective deficiency of mature CD69(low)
HSA
(low) CD8 SP cells. In the spleen and lymph nodes, the numbers of CD8(+) T cells were significantly reduced. These findings indicate that
GATA-3
supports development of the CD4 lineage and inhibits maturation of CD8 SP cells in the thymus.
...
PMID:Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. 1144 Oct 75
The presence of a relatively mature CD4(+) CD8(-) (SP) T cell subset in mouse thymus has been demonstrated. Composing of 10% of total CD4SP thymocytes, this subset is defined by the absence of 3G11 and 6C10 expression with a phenotype of CD69(+/-),
HSA
(med/lo) and heterogeneous for Qa-2 expression. The proliferation capability of TCRalphabeta(+) 3Gl l(-) 6C10(-) CD4(+) CD8(-) thymocytes was high while using Con A stimulus. And Con A stimulation could result in secretion of IL4, IL-10, IL-6 and a little amount of IFNgamma. IL-2 was barely detectable. This is distinct from typical Th0 type cytokines. The cells of this subset were NK1.1 negative, but strongly expressed
GATA-3
mRNA. The results suggest that the CD4(+) subset of 3G11(-) 6C10(-) NK1.1(-) phenotype possesses immunocompetent cells with functions characteristic of Th2-like cytokines, which may indicate the cells at transitional status from Th0 to Th2, with a propensity to Th2.
...
PMID:Characterization of a murine thymic CD4(+) T cell subset-TCRalphabeta (+) 3G11 (-) 6C10 (-) CD4 (+) CD8 (-) thymocytes. 1876 36